Below are the financial statements of Xylem, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
All figures in millions of USD | 2024 | 2023 |
---|---|---|
Current assets | — | — |
Cash and cash equivalents | 1,121a | 1,019a |
Receivables, less allowances for discounts, returns and credit losses of $59 and $56 in 2024 and 2023, respectively | 1,668a | 1,617a |
Inventories | 996a | 1,018a |
Prepaid and other current assets | 236a | 230a |
Assets held for sale | 77a | 0a |
Total current assets | 4,098a | 3,884a |
Assets | — | — |
Property, plant and equipment, net | 1,152a | 1,169a |
Goodwill | 7,980a | 7,587a |
Other intangible assets, net | 2,379a | 2,529a |
Other non-current assets | 884a | 943a |
Total assets | 16,493a | 16,112a |
Current liabilities | — | — |
Accounts payable | 1,006a | 968a |
Accrued and other current liabilities | 1,271a | 1,221a |
Short-term borrowings and current maturities of long-term debt | 38a | 16a |
Liabilities held for sale | 21a | 0a |
Total current liabilities | 2,336a | 2,205a |
Liabilities, redeemable noncontrolling interest, and stockholders' equity | — | — |
Long-term debt, net | 1,978a | 2,268a |
Accrued post-retirement benefit obligations | 304a | 344a |
Deferred income tax liabilities | 497a | 557a |
Other non-current accrued liabilities | 496a | 562a |
Total liabilities | 5,611a | 5,936a |
Redeemable non-controlling interest | 235a | 0a |
Stockholders’ equity | — | — |
Common stock - par value $0.01 per share: Authorized 750.0 shares, issued 259.2 and 257.6 shares in 2024 and 2023, respectively | 3a | 3a |
Capital in excess of par value | 8,687a | 8,564a |
Retained earnings | 3,140a | 2,601a |
Treasury stock - at cost 16.2 shares and 16.0 shares in 2024 and 2023, respectively | -753a | -733a |
Accumulated other comprehensive loss | -435a | -269a |
Total stockholders’ equity | 10,642a | 10,166a |
Non-controlling interest | 5a | 10a |
Total equity | 10,647a | 10,176a |
Total liabilities, redeemable non-controlling interest, and stockholders' equity | 16,493a | 16,112a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Xylem’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.